ThinkSabio

$AKTS

$19.30▲ -0.7% YTD

2 SEC 13D/G filings tracked · Last updated Oct 1, 2026

Filing History
News
AKTS ▼ -0.7% - Aktis Oncology, Inc.
CP $19.30▲ -0.7%Oct 1, 2026 · ThinkSabio Blog

$AKTS - Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3…

News
AKTS ▲ +2.1% - Aktis Oncology, Inc.
CP $25.52▲ +2.1%Sep 9, 2026 · ThinkSabio Blog

$AKTS - Aktis Oncology to Present at Upcoming September Investor Conferences…